Insider Buying Frenzy: Ascendis Pharma Director Jean‑Jacques Biénaime Adds 2,900 Shares Amid Social‑Media Surge and Bullish Sentiment Pulse.
Insider buys 2,900 shares of Ascendis Pharma, signaling confidence and potential upside for investors.
3 minutes to read

